| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | Jul 23, 2024 | Labrosse Nicole SVP CFO | Sell | Halozyme Therapeutics, Inc. | HALO | $53.93 | $269,662 | -24.41% |
| Jun 26, 2024 | Jun 28, 2024 | Labrosse Nicole SVP CFO | Sell | Halozyme Therapeutics, Inc. | HALO | $51.93 | $2M | -65.96% |
| Feb 16, 2023 | Feb 22, 2023 | Labrosse Nicole SVP CFO | Sell | Halozyme Therapeutics, Inc. | HALO | $49.26 | $124,382 | -21.78% |
| Nov 15, 2022 | Nov 17, 2022 | Labrosse Nicole SVP CFO | Sell | Halozyme Therapeutics, Inc. | HALO | $53.81 | $269,053 | -55.28% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.